M2 Macrophage-Derived Exosomes Inhibit Atherosclerosis Progression by Regulating the Proliferation, Migration, and Phenotypic Transformation of Smooth Muscle Cells
Authors:
Open Access
- 19 August 2024
- journal article
- research article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 29 (8) , 288
Abstract
Background: Vascular smooth muscle cell (VSMC) intimal migration, proliferation, and phenotypic transformation from a contractile to a synthetic state are hallmarks of the progression of atherosclerotic plaques. This study aims to explore the effects of exosomes derived from M2 macrophages (ExoM2) on the pathological changes of VSMCs in atherosclerosis (AS). Methods: Cell Counting Kit-8 (CCK8) and wound healing assays were used to examine the impact of ExoM2 on platelet-derived growth factor-BB (PDGF-BB)-induced VSMC proliferation and migration, respectively. Western blotting was employed to analyze changes in the expression levels of contractile markers (e.g., alpha-smooth muscle actin [α-SMA]) and synthetic ones (e.g., osteopontin [OPN]) in VSMCs with or without ExoM2 treatment. ApoE-/- mice on a high fat diet were utilized to observe the effects of ExoM2 on plaque progression and stability. Serial histopathological analysis was performed to elucidate the cellular mechanisms underlying the atheroprotective effects of ExoM2. Results: Compared with controls, ExoM2 significantly inhibited PDGF-BB-induced VSMC proliferation, migration, and phenotypic transformation in vitro. In ApoE-/- mice, ExoM2 treatment led to a marked reduction in plaque size, necrotic core area, the CD68/α-SMA ratio, and matrix metalloproteinase 9 (MMP9) and OPN levels, while enhancing plaque stability. Conclusions: ExoM2 inhibit AS progression by regulating VSMC proliferation, migration, and phenotypic transformation.Keywords
Funding Information
- National Natural Science Foundation of China (81970387, 81200213)
- Medical Scientific Research Project of Jiangsu Provincial Health Commission (Z2021069)
This publication has 38 references indexed in Scilit:
- Engineered M2 macrophage-derived extracellular vesicles with platelet membrane fusion for targeted therapy of atherosclerosisBioactive Materials, 2024
- Exosomal miR-27b-3p secreted by visceral adipocytes contributes to endothelial inflammation and atherogenesisCell Reports, 2023
- Atherosclerosis: Recent developmentsCell, 2022
- M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarizationJournal of Controlled Release, 2022
- miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotypeBiomaterials, 2021
- Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapyActa Biomaterialia, 2021
- MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese miceCell Metabolism, 2021
- Microparticles (Exosomes) and AtherosclerosisCurrent Atherosclerosis Reports, 2020
- Semaphorin-3A protects against neointimal hyperplasia after vascular injuryEBioMedicine, 2019
- Effects of Plantago major L. leaf extracts on oral epithelial cells in a scratch assayJournal of Ethnopharmacology, 2012